These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 11980322)

  • 1. [The death of drug safety and compliance?].
    Hennemann A
    Med Monatsschr Pharm; 2002 Apr; 25(4):109. PubMed ID: 11980322
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharma's year of trouble and strife.
    Frantz S
    Nat Rev Drug Discov; 2006 Jan; 5(1):7-9. PubMed ID: 16485339
    [No Abstract]   [Full Text] [Related]  

  • 3. [Some aspects on drug safety control].
    Pekkarienen A
    Nord Med; 1967 Nov; 78(47):1539-42. PubMed ID: 6075273
    [No Abstract]   [Full Text] [Related]  

  • 4. An audience with James Greenwood.
    Greenwood J
    Nat Rev Drug Discov; 2008 Jun; 7(6):470. PubMed ID: 18511925
    [No Abstract]   [Full Text] [Related]  

  • 5. New countermeasures considered as drug counterfeiting grows.
    Schubert C
    Nat Med; 2008 Jul; 14(7):700. PubMed ID: 18607355
    [No Abstract]   [Full Text] [Related]  

  • 6. Institute of Medicine's new drug safety report: implications for Canada.
    Cassels A
    CMAJ; 2006 Dec; 175(12):1515-6. PubMed ID: 17146086
    [No Abstract]   [Full Text] [Related]  

  • 7. Toxicity testing in the 21st century: a view from the pharmaceutical industry.
    MacDonald JS; Robertson RT
    Toxicol Sci; 2009 Jul; 110(1):40-6. PubMed ID: 19435982
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of globalization of drug manufacturing, production, and sourcing and challenges for American drug safety.
    Woo J; Wolfgang S; Batista H
    Clin Pharmacol Ther; 2008 Mar; 83(3):494-7. PubMed ID: 18253142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmaceutical industry financial performance.
    Goodman M
    Nat Rev Drug Discov; 2009 Dec; 8(12):927-8. PubMed ID: 19949398
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug warranties and shared responsibility.
    Malik P
    Can J Cardiol; 2005 Apr; 21(5):403. PubMed ID: 15861256
    [No Abstract]   [Full Text] [Related]  

  • 11. China's deadly drug problem.
    Cyranoski D
    Nature; 2007 Apr; 446(7136):598-9. PubMed ID: 17410150
    [No Abstract]   [Full Text] [Related]  

  • 12. WHO wants safer medicines for children.
    Choonara I
    Arch Dis Child; 2008 Jun; 93(6):456-7. PubMed ID: 18495908
    [No Abstract]   [Full Text] [Related]  

  • 13. Strength and honor through the pharmaceutical industry's embrace of green chemistry?
    Fortunak J; Confalone PN; Grosso JA
    Curr Opin Drug Discov Devel; 2007 Nov; 10(6):651-3. PubMed ID: 17987518
    [No Abstract]   [Full Text] [Related]  

  • 14. An audience with... Jan M. Lundberg.
    Lundberg JM
    Nat Rev Drug Discov; 2005 Jun; 4(6):452. PubMed ID: 15959949
    [No Abstract]   [Full Text] [Related]  

  • 15. Transparency of EU medicines agencies.
    Kopp C
    Prescrire Int; 2003 Aug; 12(66):156. PubMed ID: 12908499
    [No Abstract]   [Full Text] [Related]  

  • 16. Elderly patients and their pills: the role of compliance in safe and effective drug use.
    Lipton HL
    Pride Inst J Long Term Home Health Care; 1989; 8(1):26-31. PubMed ID: 10318212
    [No Abstract]   [Full Text] [Related]  

  • 17. Your health in the 21st century. A better safety net.
    Rosenberg D
    Newsweek; 2005; 145(26A):70-2. PubMed ID: 16375152
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of serious adverse drug reactions: a proactive pharmacovigilance program (RADAR) vs safety activities conducted by the Food and Drug Administration and pharmaceutical manufacturers.
    Bennett CL; Nebeker JR; Yarnold PR; Tigue CC; Dorr DA; McKoy JM; Edwards BJ; Hurdle JF; West DP; Lau DT; Angelotta C; Weitzman SA; Belknap SM; Djulbegovic B; Tallman MS; Kuzel TM; Benson AB; Evens A; Trifilio SM; Courtney DM; Raisch DW
    Arch Intern Med; 2007 May; 167(10):1041-9. PubMed ID: 17533207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drugs in pregnancy: acknowledging challenges--finding solutions.
    Koren G; MacLeod S; Davis D
    Can J Clin Pharmacol; 2007; 14(1):e2-4. PubMed ID: 17213506
    [No Abstract]   [Full Text] [Related]  

  • 20. An underrecognized challenge in evaluating postmarketing drug safety.
    Roden DM
    Circulation; 2005 Jan; 111(3):246-8. PubMed ID: 15668350
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.